Home > Boards > US Listed > Medical - Drugs > Onconova Therapeutics (ONTX)

News: $ONTX Onconova Therapeutics to Present Update at

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 49
Posts 6,412
Boards Moderated 1
Alias Born 06/04/18
160x600 placeholder
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 11/18/2019 4:05:47 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/14/2019 6:03:33 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 11/12/2019 5:31:47 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/12/2019 5:12:53 PM
Onconova Announces Five Presentations on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2019 Annual Meeting & Expos... GlobeNewswire Inc. - 11/7/2019 7:30:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 10/29/2019 6:05:06 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/24/2019 7:45:28 AM
Onconova Affirms Planned Completion of Pivotal Phase 3 INSPIRE Study of Rigosertib in Myelodysplastic Syndromes by 1H20 And P... GlobeNewswire Inc. - 10/24/2019 7:30:05 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/27/2019 3:53:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/26/2019 6:23:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/26/2019 4:17:18 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 9/26/2019 6:02:46 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/25/2019 5:42:12 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/25/2019 5:32:11 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/25/2019 6:54:53 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/25/2019 6:54:46 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/25/2019 6:54:28 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) Edgar (US Regulatory) - 9/25/2019 6:54:21 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/24/2019 4:09:15 PM
Onconova Therapeutics, Inc. Announces $3.4 Million Registered Direct Offering of Common Stock GlobeNewswire Inc. - 9/23/2019 8:52:19 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2019 4:06:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/20/2019 3:22:52 PM
Amended Statement of Beneficial Ownership (sc 13d/a) Edgar (US Regulatory) - 9/20/2019 3:21:46 PM
Onconova Therapeutics Announces Termination of Proposed Public Offering GlobeNewswire Inc. - 9/18/2019 10:05:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 9/17/2019 5:27:08 PM
whytestocks Member Level  Tuesday, 04/02/19 04:50:36 PM
Re: None
Post # of 638 
News: $ONTX Onconova Therapeutics to Present Update at the 2019 HCW Global Life Sciences Conference in London, April 7-9

NEWTOWN, Pa., April 02, 2019 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary focus on myelodysplastic syndromes (MDS), today announced that the Comp...

In case you are interested https://marketwirenews.com/news-releases/onconova-therapeutics-to-present-update-at-the-xa0-2019-hcw-global-life-sciences-conference-xa0-in-london-april-7-9-7931200.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist